FOXA1 and Familial prostate cancer: In support of this notion, loss of FOXA1 is reported to be vital in epithelial-mesenchymal transition (EMT) in multiple cell types (Song et al. 2010, Huang et al. 2016, Wang et al. 2016) including prostate cancer (Jin et al. 2013).